Reporting of suspected adverse reactionsReporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
Additional Information:
Product Details:
Minimum Order Quantity | 3000 Litre |
Product Type | Finished Product |
Usage | Hospital |
Injectable Form | Solution |
1 Box Contain (Bottle) | 12 |
Weight (Gram) | 1350 |
Bottle Material | PVC |
Quantity Per Pack | 1000 ml |
Automation Grade | Automatic |
Dose | >35ml |
Medicine Type | Allopathic |
Packaging Type | PVC |
Download Corporate Details of Shubham Corporation Download